| Drug-Target Information | ||||||||
|---|---|---|---|---|---|---|---|---|
| Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
| amiodarone | beta adrenergic receptor | small molecule | NA | drugbank , DGIDB | Disease[MeSHID:D004194] Supraventricular tachycardia[MeSHID:D013617] Ventricular Fibrillation[MeSHID:D014693] Tachycardia Ventricular[MeSHID:D017180] Atrial Fibrillation[MeSHID:D001281] Recurrence (disease attribute)[MeSHID:D012008] Tachyarrhythmia[MeSHID:D013610] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.16 | approved,investigational | inhibitor,downregulator |
| amiodarone | beta adrenergic receptor | small molecule | NA | drugbank , DGIDB | Disease[MeSHID:D004194] Supraventricular tachycardia[MeSHID:D013617] Ventricular Fibrillation[MeSHID:D014693] Tachycardia Ventricular[MeSHID:D017180] Atrial Fibrillation[MeSHID:D001281] Recurrence (disease attribute)[MeSHID:D012008] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Coronavirus Infections[MeSHID:D018352] |
0.16 | approved,investigational | inhibitor,downregulator |
| amiodarone | beta adrenergic receptor | small molecule | NA | drugbank | Disease[MeSHID:D004194] Supraventricular tachycardia[MeSHID:D013617] Ventricular Fibrillation[MeSHID:D014693] Tachycardia Ventricular[MeSHID:D017180] Atrial Fibrillation[MeSHID:D001281] Recurrence (disease attribute)[MeSHID:D012008] Tachyarrhythmia[MeSHID:D013610] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved,investigational | inhibitor,downregulator |
| amiodarone | beta adrenergic receptor | small molecule | NA | drugbank | Disease[MeSHID:D004194] Supraventricular tachycardia[MeSHID:D013617] Ventricular Fibrillation[MeSHID:D014693] Tachycardia Ventricular[MeSHID:D017180] Atrial Fibrillation[MeSHID:D001281] Recurrence (disease attribute)[MeSHID:D012008] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Coronavirus Infections[MeSHID:D018352] |
NA | approved,investigational | inhibitor,downregulator |
| amiodarone | beta adrenergic receptor | small molecule | NA | drugbank | Disease[MeSHID:D004194] Supraventricular tachycardia[MeSHID:D013617] Ventricular Fibrillation[MeSHID:D014693] Tachycardia Ventricular[MeSHID:D017180] Atrial Fibrillation[MeSHID:D001281] Recurrence (disease attribute)[MeSHID:D012008] Tachyarrhythmia[MeSHID:D013610] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved,investigational | inhibitor,downregulator |
| amiodarone | beta adrenergic receptor | small molecule | NA | drugbank | Disease[MeSHID:D004194] Supraventricular tachycardia[MeSHID:D013617] Ventricular Fibrillation[MeSHID:D014693] Tachycardia Ventricular[MeSHID:D017180] Atrial Fibrillation[MeSHID:D001281] Recurrence (disease attribute)[MeSHID:D012008] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Coronavirus Infections[MeSHID:D018352] |
NA | approved,investigational | inhibitor,downregulator |
| amiodarone | voltage gated l-type calcium channel | small molecule | NA | drugbank | Disease[MeSHID:D004194] Supraventricular tachycardia[MeSHID:D013617] Ventricular Fibrillation[MeSHID:D014693] Tachycardia Ventricular[MeSHID:D017180] Atrial Fibrillation[MeSHID:D001281] Recurrence (disease attribute)[MeSHID:D012008] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Coronavirus Infections[MeSHID:D018352] |
NA | approved,investigational | inhibitor |
| amiodarone | voltage gated l-type calcium channel | small molecule | NA | drugbank | Disease[MeSHID:D004194] Supraventricular tachycardia[MeSHID:D013617] Ventricular Fibrillation[MeSHID:D014693] Tachycardia Ventricular[MeSHID:D017180] Atrial Fibrillation[MeSHID:D001281] Recurrence (disease attribute)[MeSHID:D012008] Tachyarrhythmia[MeSHID:D013610] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved,investigational | inhibitor |
| amiodarone | voltage gated l-type calcium channel | small molecule | NA | drugbank | Disease[MeSHID:D004194] Supraventricular tachycardia[MeSHID:D013617] Ventricular Fibrillation[MeSHID:D014693] Tachycardia Ventricular[MeSHID:D017180] Atrial Fibrillation[MeSHID:D001281] Recurrence (disease attribute)[MeSHID:D012008] Tachyarrhythmia[MeSHID:D013610] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved,investigational | inhibitor |
| amiodarone | voltage gated l-type calcium channel | small molecule | NA | drugbank | Disease[MeSHID:D004194] Supraventricular tachycardia[MeSHID:D013617] Ventricular Fibrillation[MeSHID:D014693] Tachycardia Ventricular[MeSHID:D017180] Atrial Fibrillation[MeSHID:D001281] Recurrence (disease attribute)[MeSHID:D012008] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Coronavirus Infections[MeSHID:D018352] |
NA | approved,investigational | inhibitor |
| amiodarone | voltage gated l-type calcium channel | small molecule | NA | drugbank | Disease[MeSHID:D004194] Supraventricular tachycardia[MeSHID:D013617] Ventricular Fibrillation[MeSHID:D014693] Tachycardia Ventricular[MeSHID:D017180] Atrial Fibrillation[MeSHID:D001281] Recurrence (disease attribute)[MeSHID:D012008] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Coronavirus Infections[MeSHID:D018352] |
NA | approved,investigational | inhibitor |
| amiodarone | voltage gated l-type calcium channel | small molecule | NA | drugbank | Disease[MeSHID:D004194] Supraventricular tachycardia[MeSHID:D013617] Ventricular Fibrillation[MeSHID:D014693] Tachycardia Ventricular[MeSHID:D017180] Atrial Fibrillation[MeSHID:D001281] Recurrence (disease attribute)[MeSHID:D012008] Tachyarrhythmia[MeSHID:D013610] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved,investigational | inhibitor |
| amiodarone | voltage-dependent t-type calcium channel subunit alpha-1i | small molecule | NA | drugbank | Disease[MeSHID:D004194] Supraventricular tachycardia[MeSHID:D013617] Ventricular Fibrillation[MeSHID:D014693] Tachycardia Ventricular[MeSHID:D017180] Atrial Fibrillation[MeSHID:D001281] Recurrence (disease attribute)[MeSHID:D012008] Tachyarrhythmia[MeSHID:D013610] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved,investigational | inhibitor |
| amiodarone | voltage-dependent t-type calcium channel subunit alpha-1i | small molecule | NA | drugbank | Disease[MeSHID:D004194] Supraventricular tachycardia[MeSHID:D013617] Ventricular Fibrillation[MeSHID:D014693] Tachycardia Ventricular[MeSHID:D017180] Atrial Fibrillation[MeSHID:D001281] Recurrence (disease attribute)[MeSHID:D012008] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Coronavirus Infections[MeSHID:D018352] |
NA | approved,investigational | inhibitor |
| amiodarone | voltage gated l-type calcium channel | small molecule | NA | drugbank | Disease[MeSHID:D004194] Supraventricular tachycardia[MeSHID:D013617] Ventricular Fibrillation[MeSHID:D014693] Tachycardia Ventricular[MeSHID:D017180] Atrial Fibrillation[MeSHID:D001281] Recurrence (disease attribute)[MeSHID:D012008] Tachyarrhythmia[MeSHID:D013610] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved,investigational | inhibitor |
| amiodarone | voltage gated l-type calcium channel | small molecule | NA | drugbank | Disease[MeSHID:D004194] Supraventricular tachycardia[MeSHID:D013617] Ventricular Fibrillation[MeSHID:D014693] Tachycardia Ventricular[MeSHID:D017180] Atrial Fibrillation[MeSHID:D001281] Recurrence (disease attribute)[MeSHID:D012008] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Coronavirus Infections[MeSHID:D018352] |
NA | approved,investigational | inhibitor |
| amiodarone | voltage gated l-type calcium channel | small molecule | NA | drugbank | Disease[MeSHID:D004194] Supraventricular tachycardia[MeSHID:D013617] Ventricular Fibrillation[MeSHID:D014693] Tachycardia Ventricular[MeSHID:D017180] Atrial Fibrillation[MeSHID:D001281] Recurrence (disease attribute)[MeSHID:D012008] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Coronavirus Infections[MeSHID:D018352] |
NA | approved,investigational | inhibitor |
| amiodarone | voltage gated l-type calcium channel | small molecule | NA | drugbank | Disease[MeSHID:D004194] Supraventricular tachycardia[MeSHID:D013617] Ventricular Fibrillation[MeSHID:D014693] Tachycardia Ventricular[MeSHID:D017180] Atrial Fibrillation[MeSHID:D001281] Recurrence (disease attribute)[MeSHID:D012008] Tachyarrhythmia[MeSHID:D013610] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved,investigational | inhibitor |
| amiodarone | voltage gated l-type calcium channel | small molecule | NA | drugbank | Disease[MeSHID:D004194] Supraventricular tachycardia[MeSHID:D013617] Ventricular Fibrillation[MeSHID:D014693] Tachycardia Ventricular[MeSHID:D017180] Atrial Fibrillation[MeSHID:D001281] Recurrence (disease attribute)[MeSHID:D012008] Tachyarrhythmia[MeSHID:D013610] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved,investigational | inhibitor |
| amiodarone | voltage gated l-type calcium channel | small molecule | NA | drugbank | Disease[MeSHID:D004194] Supraventricular tachycardia[MeSHID:D013617] Ventricular Fibrillation[MeSHID:D014693] Tachycardia Ventricular[MeSHID:D017180] Atrial Fibrillation[MeSHID:D001281] Recurrence (disease attribute)[MeSHID:D012008] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Coronavirus Infections[MeSHID:D018352] |
NA | approved,investigational | inhibitor |
| amiodarone | voltage gated l-type calcium channel | small molecule | NA | drugbank | Disease[MeSHID:D004194] Supraventricular tachycardia[MeSHID:D013617] Ventricular Fibrillation[MeSHID:D014693] Tachycardia Ventricular[MeSHID:D017180] Atrial Fibrillation[MeSHID:D001281] Recurrence (disease attribute)[MeSHID:D012008] Tachyarrhythmia[MeSHID:D013610] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved,investigational | inhibitor |
| amiodarone | voltage gated l-type calcium channel | small molecule | NA | drugbank | Disease[MeSHID:D004194] Supraventricular tachycardia[MeSHID:D013617] Ventricular Fibrillation[MeSHID:D014693] Tachycardia Ventricular[MeSHID:D017180] Atrial Fibrillation[MeSHID:D001281] Recurrence (disease attribute)[MeSHID:D012008] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Coronavirus Infections[MeSHID:D018352] |
NA | approved,investigational | inhibitor |
| amiodarone | voltage gated l-type calcium channel | small molecule | NA | drugbank | Disease[MeSHID:D004194] Supraventricular tachycardia[MeSHID:D013617] Ventricular Fibrillation[MeSHID:D014693] Tachycardia Ventricular[MeSHID:D017180] Atrial Fibrillation[MeSHID:D001281] Recurrence (disease attribute)[MeSHID:D012008] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Coronavirus Infections[MeSHID:D018352] |
NA | approved,investigational | inhibitor |
| amiodarone | voltage gated l-type calcium channel | small molecule | NA | drugbank | Disease[MeSHID:D004194] Supraventricular tachycardia[MeSHID:D013617] Ventricular Fibrillation[MeSHID:D014693] Tachycardia Ventricular[MeSHID:D017180] Atrial Fibrillation[MeSHID:D001281] Recurrence (disease attribute)[MeSHID:D012008] Tachyarrhythmia[MeSHID:D013610] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved,investigational | inhibitor |
| amiodarone | herg human cardiac k+ channel | small molecule | NA | drugbank , DGIDB | Disease[MeSHID:D004194] Supraventricular tachycardia[MeSHID:D013617] Ventricular Fibrillation[MeSHID:D014693] Tachycardia Ventricular[MeSHID:D017180] Atrial Fibrillation[MeSHID:D001281] Recurrence (disease attribute)[MeSHID:D012008] Tachyarrhythmia[MeSHID:D013610] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.08 | approved,investigational | inhibitor |
| amiodarone | herg human cardiac k+ channel | small molecule | NA | drugbank , DGIDB | Disease[MeSHID:D004194] Supraventricular tachycardia[MeSHID:D013617] Ventricular Fibrillation[MeSHID:D014693] Tachycardia Ventricular[MeSHID:D017180] Atrial Fibrillation[MeSHID:D001281] Recurrence (disease attribute)[MeSHID:D012008] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Coronavirus Infections[MeSHID:D018352] |
0.08 | approved,investigational | inhibitor |
| amiodarone | herg human cardiac k+ channel | small molecule | NA | drugbank | Disease[MeSHID:D004194] Supraventricular tachycardia[MeSHID:D013617] Ventricular Fibrillation[MeSHID:D014693] Tachycardia Ventricular[MeSHID:D017180] Atrial Fibrillation[MeSHID:D001281] Recurrence (disease attribute)[MeSHID:D012008] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Coronavirus Infections[MeSHID:D018352] |
NA | approved,investigational | inhibitor |
| amiodarone | herg human cardiac k+ channel | small molecule | NA | drugbank | Disease[MeSHID:D004194] Supraventricular tachycardia[MeSHID:D013617] Ventricular Fibrillation[MeSHID:D014693] Tachycardia Ventricular[MeSHID:D017180] Atrial Fibrillation[MeSHID:D001281] Recurrence (disease attribute)[MeSHID:D012008] Tachyarrhythmia[MeSHID:D013610] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved,investigational | inhibitor |
| amiodarone | herg human cardiac k+ channel | small molecule | NA | drugbank | Disease[MeSHID:D004194] Supraventricular tachycardia[MeSHID:D013617] Ventricular Fibrillation[MeSHID:D014693] Tachycardia Ventricular[MeSHID:D017180] Atrial Fibrillation[MeSHID:D001281] Recurrence (disease attribute)[MeSHID:D012008] Tachyarrhythmia[MeSHID:D013610] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved,investigational | inhibitor |
| amiodarone | herg human cardiac k+ channel | small molecule | NA | drugbank | Disease[MeSHID:D004194] Supraventricular tachycardia[MeSHID:D013617] Ventricular Fibrillation[MeSHID:D014693] Tachycardia Ventricular[MeSHID:D017180] Atrial Fibrillation[MeSHID:D001281] Recurrence (disease attribute)[MeSHID:D012008] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Coronavirus Infections[MeSHID:D018352] |
NA | approved,investigational | inhibitor |
| amiodarone | peroxisome proliferator-activated receptor alpha | small molecule | NA | drugbank | Disease[MeSHID:D004194] Supraventricular tachycardia[MeSHID:D013617] Ventricular Fibrillation[MeSHID:D014693] Tachycardia Ventricular[MeSHID:D017180] Atrial Fibrillation[MeSHID:D001281] Recurrence (disease attribute)[MeSHID:D012008] Tachyarrhythmia[MeSHID:D013610] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved,investigational | agonist |
| amiodarone | peroxisome proliferator-activated receptor alpha | small molecule | NA | drugbank | Disease[MeSHID:D004194] Supraventricular tachycardia[MeSHID:D013617] Ventricular Fibrillation[MeSHID:D014693] Tachycardia Ventricular[MeSHID:D017180] Atrial Fibrillation[MeSHID:D001281] Recurrence (disease attribute)[MeSHID:D012008] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Coronavirus Infections[MeSHID:D018352] |
NA | approved,investigational | agonist |
| amiodarone | peroxisome proliferator-activated receptor gamma | small molecule | NA | drugbank | Disease[MeSHID:D004194] Supraventricular tachycardia[MeSHID:D013617] Ventricular Fibrillation[MeSHID:D014693] Tachycardia Ventricular[MeSHID:D017180] Atrial Fibrillation[MeSHID:D001281] Recurrence (disease attribute)[MeSHID:D012008] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Coronavirus Infections[MeSHID:D018352] |
NA | approved,investigational | agonist |
| amiodarone | peroxisome proliferator-activated receptor gamma | small molecule | NA | drugbank | Disease[MeSHID:D004194] Supraventricular tachycardia[MeSHID:D013617] Ventricular Fibrillation[MeSHID:D014693] Tachycardia Ventricular[MeSHID:D017180] Atrial Fibrillation[MeSHID:D001281] Recurrence (disease attribute)[MeSHID:D012008] Tachyarrhythmia[MeSHID:D013610] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved,investigational | agonist |
| amiodarone | peroxisome proliferator-activated receptor gamma coactivator 1-beta | small molecule | NA | drugbank | Disease[MeSHID:D004194] Supraventricular tachycardia[MeSHID:D013617] Ventricular Fibrillation[MeSHID:D014693] Tachycardia Ventricular[MeSHID:D017180] Atrial Fibrillation[MeSHID:D001281] Recurrence (disease attribute)[MeSHID:D012008] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Coronavirus Infections[MeSHID:D018352] |
NA | approved,investigational | agonist |
| amiodarone | peroxisome proliferator-activated receptor gamma coactivator 1-beta | small molecule | NA | drugbank | Disease[MeSHID:D004194] Supraventricular tachycardia[MeSHID:D013617] Ventricular Fibrillation[MeSHID:D014693] Tachycardia Ventricular[MeSHID:D017180] Atrial Fibrillation[MeSHID:D001281] Recurrence (disease attribute)[MeSHID:D012008] Tachyarrhythmia[MeSHID:D013610] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved,investigational | agonist |
| click here to return to the previous page | ||||||||